AllSquare Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-170
| Closed | -$15.3K | – | 553 |
|
|
2024
Q4 | $15.3K | Buy |
+170
| New | +$15.3K | 0.01% | 333 |
|
|
2024
Q2 | – | Sell |
-236
| Closed | -$22.4K | – | 544 |
|
|
2024
Q1 | $22.4K | Hold |
236
| – | – | 0.01% | 284 |
|
|
2023
Q4 | $21.1K | Hold |
236
| – | – | 0.01% | 290 |
|
|
2023
Q3 | $17.2K | Hold |
236
| – | – | 0.01% | 311 |
|
|
2023
Q2 | $19.6K | Sell |
236
-130
| -36% | -$10.8K | 0.01% | 301 |
|
|
2023
Q1 | $27.9K | Hold |
366
| – | – | 0.02% | 274 |
|
|
2022
Q4 | $30.4K | Hold |
366
| – | – | 0.02% | 250 |
|
|
2022
Q3 | $29K | Hold |
366
| – | – | 0.02% | 247 |
|
|
2022
Q2 | $27K | Hold |
366
| – | – | 0.02% | 264 |
|
|
2022
Q1 | $33K | Hold |
366
| – | – | 0.02% | 263 |
|
|
2021
Q4 | $41K | Hold |
366
| – | – | 0.02% | 244 |
|
|
2021
Q3 | $46K | Hold |
366
| – | – | 0.03% | 232 |
|
|
2021
Q2 | $50K | Hold |
366
| – | – | 0.03% | 235 |
|
|
2021
Q1 | $50K | Hold |
366
| – | – | 0.03% | 229 |
|
|
2020
Q4 | $52K | Buy |
366
+28
| +8% | +$3.98K | 0.03% | 194 |
|
|
2020
Q3 | $38K | Buy |
338
+45
| +15% | +$5.06K | 0.03% | 225 |
|
|
2020
Q2 | $33K | Hold |
293
| – | – | 0.02% | 220 |
|
|
2020
Q1 | $23K | Buy |
293
+163
| +125% | +$12.8K | 0.02% | 237 |
|
|
2019
Q4 | $12K | Hold |
130
| – | – | 0.01% | 314 |
|
|
2019
Q3 | $10K | Buy |
+130
| New | +$10K | 0.01% | 326 |
|